Macrophage Inflammatory Protein—1 Alpha: A Paradox?

References

• Miller, M. and Krangel, M. (1992). Biology and biochemistry of the chemokines: A family of chemo tactic and inflammatory cytokines. Crit. Rev. Immunology, 12, 17–46.
   PubMed Web of Science ®Google Scholar
• Schall, T. (1991). Biology of the RANTES/SIS cytokine family. Cytokine, 3, 165–183.
   PubMed Web of Science ®Google Scholar
• Broxmeyer, H., Sherry, B., Lu, L., Cooper, S., Oh, K.-O., Tekamp-Olson, P., Kwon, B. and Cerami, A. (1990). Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood, 76, 1110–1116.
   PubMed Web of Science ®Google Scholar
• Youn, B.-S., Jang, I.-K., Broxmeyer, H., Cooper, S., Jenkins, N., Gilbert, D., Copeland, N., Elick, T., Fraser, M. and Kwon, B. (1995). A novel chemokine, macrophage inflammatory related protein-2, inhibits colony formation of marrow myeloid progenitors. J. Immunol., 155, 2661–2667.
   PubMed Web of Science ®Google Scholar
• Han, Z., Senesebe, L., Abgrall, J. and Briere, J. (1990). Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood, 75, 1234–1239.
   PubMed Web of Science ®Google Scholar
• Gewirtz, A., Zhang, J., Ratajczak, J., Ratajczak, M., Park, K., Li, C., Yan, Z. and Poncz, M. (1995). Chemokine regulation of human megakaryocytopoiesis. Blood, 86, 2559–2567.
   PubMed Web of Science ®Google Scholar
• Chaudhuri, A., Zbrzezna, V., Polyakova, J., Pogo, A. O., Hesselgesser, J. and Horuk, R. (1994). Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. Journal of Biological Chemistry, 269, 7835–8.
   PubMed Web of Science ®Google Scholar
• Murphy, P. (1996). Chemokine receptors: Structure, function and role in microbial pathogenesis. Cytokine and growth factor reviews, 7, 47–64.
   PubMedGoogle Scholar
• Cocchi, F., DeVico, A., Garzino-Demo, A., Cara, A., Gallo, R. and Lusso, P. (1996). The V3 domain of the HIV-1 gp 120 envelope glycoprotein is critical for chemokine mediated blockade of the infection. Nature Med., 2, 1244.
   PubMed Web of Science ®Google Scholar
• Wilkinson, D. (1996). HIV-1: Cofactors provide the entry keys. Curr Biol., 6, 1051.
   PubMed Web of Science ®Google Scholar
• Samson, M., Libert, F., Doranz, B. and others (1996). Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722.
   PubMed Web of Science ®Google Scholar
• Wolpe, S., Davatelis, G., Sherry, B., Beutler, B., Hesse, D., Nguyen, H., Moldawer, L., Nathan, C., Lowry, S. and Cerami, A. (1988). Macrophages secrete a novel heparinbinding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med., 167, 570–581.
   PubMed Web of Science ®Google Scholar
• Graham, G., Wright, E., Hewick, R., Wolpe, S., Wilie, N., Donaldson, D., Lorrimore, S. and Pragnell, I. (1990). Identification and characteristion of an inhibitor of haemopoietic stem cell proliferation. Nature, 344, 442–444.
   PubMed Web of Science ®Google Scholar
• Lord, B., Mori, K., Wright, E. and Latha, L. (1976). An inhibitor of stem cell proliferation in normal bone marrow. Brit J Haem., 24, 441–444.
   Web of Science ®Google Scholar
• Davetelis, G., Tekamp-Olsen, P., Wolpe, S., Hermsen, K., Luedke, C., Gallegos, C., Coit, D., Merryweather, J. and Cerami, A. (1988). Cloning and characterisation of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. Exp Med., 167, 1939.
   PubMed Web of Science ®Google Scholar
• Graham, G. J., Freshney, M. G., Donaldson, D. and Pragnell, I. B. (1992). Purification and biochemical characterisation of human and murine stem cell inhibitors (SCI). Growth Factors, 7, 151–60.
   PubMed Web of Science ®Google Scholar
• Obaru, K., Fukada, M., Maeda, S. and Shimada, K. (1986). A cDNA clone used to study mRNA inducible in human tonsillar lymhocyte by a tumor promoter. J Biochem (Tokyo), 99, 885–894.
   PubMed Web of Science ®Google Scholar
• Graham, G., Mackenzie, J., Lowe, S., Tsang, M., Weatherbee, J., Isaacson, A., Medechilda, J., Fangs, F., Wilkinson, P. and Pragnell, I. (1994). Aggregation of the chemokine MIP-1α is a dynamic and reversible phenomenon. J. Biol Chem., 269, 4974–4978.
   PubMed Web of Science ®Google Scholar
• Hunter, M., Bawden, L., Brotherton, D., Craig, S., Cribbes, S., Czaplewski, L., Dexter, T., Drummond, A., Gearing, A., Heyworth, C., Lord, B., McCourt, M., Varley, P., Wood, L., Edwards, R. and Lewis, P. (1995). BB-10010: An active variant of human macrophage inflammatory protein-1α with improved pharmaceutical properties. Blood, 86, 4400–4408.
   PubMed Web of Science ®Google Scholar
• Graham, G., Wilkinson, P., Nibbs, R., Lowe, S., Kolset, S., Parker, A., Freshney, M., Tsang, M. L.-S. and Pragnell, I. (1996). Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1α by mutagenesis of the proteoglycan binding site. EMBO, 15, 6506–6515.
   PubMed Web of Science ®Google Scholar
• Cluitmans, F., Essendam, B., Landegent, J., Willemze, R. and Falkenberg, J. (1995). Constitutive in vivo cytokine and haemopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood, 85, 2038.
   PubMed Web of Science ®Google Scholar
• Canque, B. and Gluckman, J. (1994). MIP-1 alpha is induced by and inhibits HIV infection of blood-derived macrophages. Blood, 84, 480.
   Web of Science ®Google Scholar
• Kasama, T., Strieter, R., Standiford, T., Burdick, M. and Kunkel, S. (1993). Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J Exp Med., 178, 63.
   PubMed Web of Science ®Google Scholar
• Costa, J., Matossian, J., Resnick, M., Weil, W., Wong, D., Gordon, J., Dvorak, A., Weller, P. and Galli, S. (1994). Human eosinophils can express the cytokines Tumour necrosis Factor-alpha and Macrophage Inflammatory Protein-1 alpha. J. Clin Invest., 91, 2673.
   Web of Science ®Google Scholar
• Ebisawa, M., Tachimoto, H., Saito, H. and Iikura, Y. (1996). Cultured human mast cells are capable of producing multiple cytokines and chemokines. J Allerg and Clin Immunol., 97, 706.
   Web of Science ®Google Scholar
• Li, H., Sim, T., Grant, J. and Alam, R. (1996). The production of macrophage inflammatory protein 1 alpha by human basophils. J. Immunol., 157, 1207.
   PubMed Web of Science ®Google Scholar
• Klinger, M., Wilhelm, D., Bubel, S., Sticherling, M., Schroder, J.-M. and Kuhnel, W. (1995). Immunocyto chemical localisation of the chemokines RANTES and MIP-lα within human platelets and their release during storage. Int Arch Allergy Immunol., 107, 541.
   PubMed Web of Science ®Google Scholar
• Heufler, C., Topar, G., Koch, F., Trockenbauer, B., Kampgen, E., Romani, N. and Schuler, G. (1992). Cytokine gene expression in murine epidermal Lan gerhans cells—MIP-1 alpha is a major product and inhibits the proliferation of keratinocyte stem cells. J. Exp Med., 176, 1221–1226.
   PubMed Web of Science ®Google Scholar
• Parkinson, E., Graham, G., Daubersies, P., Burns, J., Heufler, C., Plumb, M., Schuler, G. and Pragnell, I. (1993). A haemopoietic stem cell inhibitor (SCI/MIP-1α) also inhibits clonogenic epidermal keratinocyte proliferation. J. Invest Dermatol., 101, 113.
   PubMed Web of Science ®Google Scholar
• Schall, T., Bacon, K., Camp, R., Kaspari, J. and Goeddel, D. (1993). Human macrophage inflammatory protein-1α (MIP-1α) and MIP-1α chemokines attract distinct populations of lymphocytes. J Exp Med., 177, 1821.
   PubMed Web of Science ®Google Scholar
• Lukacs, N., Strieter, R., Elner, V., Evanoff, H., Burdick, M. and Kunkel, S. (1994). Intercellular adhesion molecule-1 mediates the expression of monocyte derived MIP-1α during monocyte-endothelial interactions. Blood, 83, 1174–1178.
   PubMed Web of Science ®Google Scholar
• Vaddi, K. and Newton, R. (1994). Regulation of monocyte integrin expression by β-family chemokines. J of Immunology, 153, 4721–4732.
   PubMed Web of Science ®Google Scholar
• Streiter, R., Standiford, T., Huffnagle, G., Coletti, L., Luckacs, L. and Kunkel, S. (1996). “The good, the bad, and the ugly”. The role of chemokines in human disease. J Immunol., 156, 3583.
   PubMed Web of Science ®Google Scholar
• Smit, R., Strieter, R., S. S. P., Lukas, N., Huffnagel, G., Wilke, C., Burdick, M., Lincoln, P., Evanoff, H. and Kunkel, S. (1994). Production and function of murine macrophage inflammatory protein—1α in Bleomycin-induced lung injury. J Immunol., 153, 4704–4712.
   PubMed Web of Science ®Google Scholar
• Shanley, T., Schmal, H., Freidl, H., Jones, M. and Ward, P. (1995). Role of macrophage inflammatory protein-1α (MIP-1α) in acute lumg injury in rats. J Immunol., 154, 4793.
   PubMed Web of Science ®Google Scholar
• Cook, D. N., Beck, M. A., Coffman, T. M., Kirby, S. L., Sheridan, J. F., Pragnell, I. B. and Smithies, O. (1995). Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science, 269, 1583–5.
   PubMed Web of Science ®Google Scholar
• Boggs, S., Bray, J., Greenberger, J., Smithies, O. and Cook, D. (1995). Prolonged cell production in long term marrow cultures from mice lacking macrophage protein (MIP)—1a. Blood, 86, abs 36.
   Web of Science ®Google Scholar
• Holyoake, T. L., Freshney, M. G., Sproul, A. M., Richmond, L. J., Alcorn, M. J., Steward, W. P., Fitzsimons, E., Dunlop, D. J., Franklin, I. M. and Pragnell, I. B. (1993). Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro. Stem Cells, 11, 122–8.
   PubMed Web of Science ®Google Scholar
• Clements, J., Craig, S., Gearing, A., Hunter, M., Heyworth, C., Dexter, T. and Lord, B. (1992). Biological and structural properties of MIP-1α expressed in yeast. Cytokine, 4, 76–82.
   PubMed Web of Science ®Google Scholar
• Keller, J. R., Bartelmez, S. H., Sitnicka, E., Ruscetti, F. W., Ortiz, M., Gooya, J. M. and Jacobsen, S. E. (1994). Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth. Blood, 84, 2175–81.
   PubMed Web of Science ®Google Scholar
• Bonnet, D., Lemoine, F. M., Najman, A. and Guigon, M. (1995). Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow purified CD34+ progenitors. Experimental Hematology, 23, 551–6.
   PubMed Web of Science ®Google Scholar
• Quesniaux, V. F., Graham, G. J., Pragnell, I., Donaldson, D., Wolpe, S. D., Iscove, N. N. and Fagg, B. (1993). Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1 alpha on long-term reconstituting stem cells in vivo. Blood, 81, 1497–504.
   PubMed Web of Science ®Google Scholar
• Eaves, C., Cashman, J., Wolpe, S. and Eaves, A. (1993). Unresponsiveness of primitive chronic myeloid leukaemia cells to macrophage inflammatory protein 1 α, an inhibitor of primitive normal hematopoietic cells. PNAS, 90, 12015–12019.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M., Catanzarro, P. M. and Li, W. N. (1994). Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. Journal of Experimental Medicine, 179, 643–9.
   PubMed Web of Science ®Google Scholar
• Lord, B. (1995). MIP-1α increases the self-renewal capacity of the hemopoietic spleen-colony forming cells following hydroxyurea in vivo. Growth Factors, 12, 145–149.
   PubMed Web of Science ®Google Scholar
• Soma, T., Yu, J. M. and Dunbar, C. (1996). Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-β but not by macrophage inflammatory protein-1α activities. Blood, 87, 4561–4567.
   PubMed Web of Science ®Google Scholar
• Moore, M. (1991). Clinical implications of positive and negative hematopoietic stem cell regulators. Blood, 78, 1–19.
   PubMed Web of Science ®Google Scholar
• Dunlop, D. J., Wright, E. G., Lorimore, S., Graham, G. J., Holyoake, T., Kerr, D. J., Wolpe, S. D. and Pragnell, I. B. (1992). Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo. Blood, 79, 2221–5.
   PubMed Web of Science ®Google Scholar
• Lord, B., Dexter, T., Clements, J., Hunter, M. and Gearing, A. (1992). Macrophage inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effect of hydroxyurea in vivo. Blood, 79, 2605–2609.
   PubMed Web of Science ®Google Scholar
• Parker, A., Sim, A., McNair, L., Graham, G. and Pragnell, I. (1996). MIP-1α ameliorates primitive pro-genitor loss/damage due to Cyclophosphamide in vivo. Brit J Haem., 93, abs 1066.
   PubMed Web of Science ®Google Scholar
• Gilmore, G., DePasquala, D. and Shadduck, R. (1996). BB10010, a synthetic variant of MIP-1α, reduces neutropenia interval in cyclophosphamide treated mice. Blood, 88, 136b abs 3270.
   Web of Science ®Google Scholar
• Marshall, E., Woolford, L. and Lord, B. (1997). Continuous infusion of macrophage inflammatory protein MIP-1α enhances leucocyte recovery and haemopoietic progenitor mobilisation after cyclophosphamide. Brit J Cancer, 75, 1715–1720.
   PubMed Web of Science ®Google Scholar
• Lord, B., Marshall, E., Woolford, L. and Hunter, M. (1996). BB10010/MIP-1α in vivo maintains haemopoietic recovery following repeated cycles of sublethal radiation. Brit J Cancer, 74, 1017–1022.
   PubMed Web of Science ®Google Scholar
• Lord, B., Woolford, L., Czaplewski, L., McCourt, M., Hunter, M. and Edwards, R. (1995). Mobilisation of early hematopoietic progenitor cells with BB-10010: A genetically engineered variant of human macrophage inflammatory protein-1α. Blood, 85, 3412–3415.
   PubMed Web of Science ®Google Scholar
• Watts, M., Addison, I., Sullivan, A., Chavda, N., Jamieson, E., Hunter, M., Czaplewski, L., Wood, M. and Linch, D. (1996). Effects of a single dose of BB-10010 on progenitor cell mobilisation after cyclophosphamide. Brit J Haem., 93, 277 abs 1049.
   Web of Science ®Google Scholar
• Ferrajoli, A., Talpaz, M., Zipf, T., Hirsch-Ginsberg, C., Estey, E., Wolpe, S. and Esrov, Z. (1994). Inhibition of acute myeloid leukaemia progenitor proliferation by macrophage inflammatory protein-1α. Leukaemia, 8, 798–805.
   PubMed Web of Science ®Google Scholar
• Lynch, P. O., Adams, J., Bereton, M., Czaplewski, L., Whettton, A. and Yin, J. (1996). The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia. Brit J Haem., 95, 77–84.
   PubMed Web of Science ®Google Scholar
• Yamamura, F., Hattori, T., Obaru, K., Sakai, K., Asoun, N., Takasuki, K., Ohmoto, Y., Nomiyama, M. and Snimada, K. (1989). Synthesis of a novel cytokine and its gene (LD78) expressions in haemopoietic fresh tumor and cell lines. J. Clin Invest, 84, 1707–1712.
   PubMed Web of Science ®Google Scholar
• Hunter, M., Wood, L., Patou, G., Galloway, W., Edwards, R., Czaplewski, L., Millar, A., Powles, R., Lord, B., Dexter, T. and Lewis, P. (1996). BB-10010, a variant of human MIP-1α engineered for clinical evaluation. Brit J Haem., 93, 270 abs 1020.
   Web of Science ®Google Scholar